The purpose of this survey is to provide an overview of the third goal of Oregon's Viral Hepatitis Elimination Plan, Eliminate Health Disparities and Inequities, and solicit feedback from a wide variety of partners.
 
For the goal of eliminating health disparities and inequities, we propose two main objectives that represent changes, outcomes and impacts that we want to achieve: 
 
1) Reduce stigma and discrimination in healthcare settings faced by people with or at increased risk for viral hepatitis, and
2) Reduce disparities in diagnosis of viral hepatitis, knowledge of status, engagement with care, and community stigma around diagnosis

We want your opinion on the proposed strategies and to hear about what we are missing.  What strategies does your agency or healthcare facility already employ, and are there additional strategies that you could implement? As you go through the document, we have boxes at the end of each set of strategies where we would love your feedback on each aspect.
 

Question Title

* 1. Please select the following groups you represent. Please select all that apply. 

Question Title

* 2. Please add your name or email

Question Title

* 3. 1. Reduce stigma and discrimination in healthcare settings faced by people with or at increased risk for viral hepatitis

A. Address stigma, unconscious bias, and discriminatory practices at health care delivery sites

o  Increase culturally competent care navigation services and care management in primary care and emergency department settings

o   Promote recruitment of culturally and linguistically diverse community health workers to provide care navigation

o   Provide trainings on implicit bias and microaggression for clinic staff

o   Foster collaboration between healthcare systems and community-based organizations that serve priority populations to implement effective strategies for improving viral hepatitis care and treatment

Question Title

* 4. 1. Reduce stigma and discrimination in healthcare settings faced by people with or at increased risk for viral hepatitis

B. Expand culturally competent and linguistically appropriate care, treatment, and prevention services

o   Promote recruitment of linguistically and culturally diverse staff in healthcare and MOUD/SUD treatment sites

o   Ensure that hepatitis and substance use recovery materials are available and translated into languages representing the populations utilizing clinic services

o   Develop additional culturally and linguistically responsive educational materials tailored to communities with a high prevalence of viral hepatitis, HIV and STIs, including videos, infographics, audio materials for radio or podcasts, and social media messaging

o   Ensure interpreter service is available at healthcare and MOUD/SUD treatment facilities care

Question Title

* 5. 2. Reduce disparities in diagnosis of viral hepatitis, knowledge of status, engagement with care, and community stigma around diagnosis

A. Strengthen and build partnerships with organizations serving communities at risk for viral hepatitis to raise awareness

o   Foster partnerships with organizations that serve disproportionately impacted populations, including community organizations, provider organizations, academic institutions, and offices of minority health, to raise awareness of viral hepatitis

o   Promote hepatitis prevention education, hepatitis treatment, and MOUD/SUD treatment for individuals in carceral settings

Question Title

* 6. 2. Reduce disparities in diagnosis of viral hepatitis, knowledge of status, engagement with care, and community stigma around diagnosis

B. Engage community leaders and people with lived experience to dispel viral hepatitis–related stigma

o   Employ more peer educators to raise awareness about HCV prevention and the availability of a cure in their respective communities

o   Share facts, recommendations, and personal stories in community settings and in the media to reach all people, especially those in disproportionately impacted communities

o   Increase social media campaigns highlighting treatment for HCV and lived experience of living with chronic hepatitis

T